Call us now:
Poor computer security may have been the reason an acquirer pulled out of the $4.3billion acquisition of Akorn, a generic drugs maker.
Poor computer security may have been the reason an acquirer pulled out of the $4.3billion acquisition of Akorn, a generic drugs maker. Exposing wider questions around the provinonce of data. View Original Post
